DMIIU — Drugs Made In America Acquisition II Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2040475 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -102,030 | 4,337,820 | 509,725,411 | 347,720 | 18,166,285 |
| Dec 2025 | 0 | — | -1,047,585 | 4,330,608 | 504,959,837 | 223 | 17,800,864 |
| Sep 2025 | 0 | — | -155,513 | -46,158 | 501,005,711 | 315,087 | 18,177,345 |
| Jun 2025 | 0 | — | -38,073 | -38,073 | 113,395 | 4,394 | 327,514 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,018,231
Investing CF
$0
Financing CF
$501,001,419
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,776,196
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-1,300,498
Pretax Income TTM
$4,187,050
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,300,498 | 4,187,050 | 504,959,837 | 17,800,864 | — | -1,018,231 |
| Dec 2024 | — | — | — | 138,064 | 254,783 | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $5.27B | $41.21 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $641.46M | $10.07 | — |
| INV | Innventure, Inc. | $536.21M | $6.38 | — |
| BCSS | Bain Capital GSS Investment Corp. | $478.38M | $10.20 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $477.46M | $10.17 | — |
News headlines (Yahoo Finance, 1h cache)
NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
2026-02-24 21:42 · Yahoo
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
2025-12-04 15:05 · Yahoo
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
2025-12-03 11:34 · Yahoo
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
2025-09-26 20:05 · Yahoo
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
2025-09-25 10:43 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.